Last $18.58 USD
Change Today +0.92 / 5.21%
Volume 654.9K
RGLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for regulus therapeutics inc (RGLS)

Year over year, Regulus Therapeutics Inc. has been seen their bottom line shrink from a loss of $17.4M USD to an even larger loss of $18.7M USD. despite revenues that grew from $12.7M USD to $19.6M USD over the same time period.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues8.613.812.719.6
TOTAL REVENUES8.613.812.719.6
Cost of Goods Sold20.217.320.329.9
GROSS PROFIT-11.6-3.5-7.6-10.4
Selling General & Admin Expenses, Total3.93.64.97.4
OTHER OPERATING EXPENSES, TOTAL3.93.64.97.4
OPERATING INCOME-15.5-7.1-12.6-17.8
Interest Expense-0.4-0.4-0.20.0
Interest and Investment Income0.30.10.10.3
NET INTEREST EXPENSE-0.1-0.3-0.10.3
EBT, EXCLUDING UNUSUAL ITEMS-15.6-7.4-12.7-17.5
Other Unusual Items, Total-----4.7-1.1
Other Unusual Items-----4.7-1.1
EBT, INCLUDING UNUSUAL ITEMS-15.6-7.4-17.4-18.7
Income Tax Expense0.00.20.00.0
Earnings from Continuing Operations-15.6-7.6-17.4-18.7
NET INCOME-15.6-7.6-17.4-18.7
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-15.6-7.6-17.4-18.7
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-15.6-7.6-17.4-18.7
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $18.58 USD +0.92

RGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$0.77 AUD +0.015
Galena Biopharma Inc $1.63 USD -0.02
Prosensa Holding NV $18.68 USD -0.05
Silence Therapeutics PLC 222.00 GBp -2.00
Tekmira Pharmaceuticals Corp C$32.90 CAD +1.05
View Industry Companies
 

Industry Analysis

RGLS

Industry Average

Valuation RGLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 54.9x
Price/Book 9.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 53.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.